Real-world Impact of Tezepelumab in Severe Asthma: insights from the ADVANCAT Study (Advancing Severe Asthma Care with Tezepelumab in Catalonia)


Por: Arismendi, E, Basagaña, M, Crespo, A, Luengo, O, Martinez-Rivera, C, Muñoz-Esquerre, M, Paredes, M, Ojanguren, I and Munoz, X

Publicada: 1 sep 2025
Resumen:


Filiaciones:
Arismendi, E:
 Univ Barcelona, Hosp Clin Barcelona, Pulmonol Dept, CIBERES, Barcelona, Spain

:
 Hosp Germans Trias I Pujol, Allergol Dept, Barcelona, Spain

Crespo, A:
 Hosp Santa Creu i St Pau, Pulmonol Dept, Barcelona, Spain

Luengo, O:
 Hosp Valle De Hebron, Allergol Dept, Barcelona, Spain

:
 Hosp Germans Trias i Pujol, Pulmonol Dept, Barcelona, Spain

Muñoz-Esquerre, M:
 Hosp Univ Bellvitge, Pulmonol Dept, Barcelona, Spain

Paredes, M:
 Hosp Clin Barcelona, Pulmonol Dept, Barcelona, Spain

Ojanguren, I:
 Hosp Valle De Hebron, Pulmonol Dept, Barcelona, Spain

Munoz, X:
 Hosp Valle De Hebron, Pulmonol Dept, Barcelona, Spain
ISSN: 13993003





European Respiratory Journal
Editorial
European Respiratory Society, 442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND, Reino Unido
Tipo de documento: Meeting Abstract
Volumen: 66 Número:
Páginas:
WOS Id: 001677138700028

MÉTRICAS